BIO Commends PTO Director for Withdrawal of Harmful Rules

  • Contact: Contact Stephanie Fischer
    (202) 312-9263 or [email protected]
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (Thursday, October 08, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today on the decision by David J. Kappos, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (PTO), to withdraw the agency’s proposed rules restricting continuation and claims practice, which had been opposed by BIO and challenged in court by GlaxoSmithKline:

“BIO applauds the action by Under Secretary Kappos today to formally withdraw the controversial and harmful proposed rules that would have limited the ability of biotechnology applicants to secure full coverage of their inventions.  This action is a positive sign that the new Administration wants to work in a constructive manner with the patent applicant community to address the serious challenges facing the PTO, and BIO stands ready to work with Under Secretary Kappos and others at the PTO to do so.”

Upcoming BIO Events 

BIO Investor Forum
October 28-29, 2009
San Francisco, CA

Advanced Business Development Course
October 30, 2009
Vienna, Austria

BIO Europe International Partnering Conference
November 2-4, 2009
Vienna, Austria

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
Honolulu, HI 

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.